Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Selsavage Joseph Anthony | Interim CFO | 17 | $0 | $0 | 2025-02-20 |
| Chung Patrick S | Director | 9 | $0 | $0 | 2024-08-26 |
| Mohan Neal | Director | 5 | $0 | $0 | 2024-08-26 |
| MONTGOMERY RICE VALERIE MD | Director | 11 | $0 | $0 | 2024-08-26 |
| Taylor Peter J. | Director | 7 | $0 | $0 | 2024-08-26 |
| Hernandez Sandra R MD | Director | 11 | $0 | $0 | 2024-08-26 |
| BOTHA ROELOF | Director, 10% Owner | 9 | $0 | $0 | 2024-08-26 |
| SCHELLER RICHARD H | Director | 6 | $0 | $59.7K | 2024-08-26 |
| Richards William G | Head of Therapeutics Discovery | 9 | $0 | $2.7K | 2024-08-20 |
| HIBBS KATHY L | Chief Legal Officer | 87 | $0 | $924.1K | 2024-05-20 |
| Wojcicki Anne | Chief Executive Officer | 2 | $0 | $0 | 2023-09-15 |
| Hillan Kenneth J. | Head of Therapeutics | 10 | $0 | $31.9K | 2023-06-05 |
| Schoch Steven J | Chief Financial Officer | 4 | $0 | $0 | 2022-08-20 |
| Lovell Evan | Director | 4 | $50.6K | $0 | 2022-08-11 |
| Johnson Paul D | VP, General Manager-Consumer | 10 | $0 | $0 | 2022-02-09 |
| Keim Tracy | VP, Consumer Marketing & Brand | 2 | $0 | $0 | 2022-02-09 |
| Lemon Steven | Vice President, Engineering | 4 | $0 | $0 | 2022-02-09 |
| Kohler Frederick Mark | Vice President, People | 2 | $0 | $0 | 2022-02-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | F Tax w/h | 2025-02-20 | 2025-02-21 | 5,654 | $2.74 | $15.5K | 96,468 | SEC↗ |
| Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | F Tax w/h | 2024-11-20 | 2024-11-21 | 5,279 | $3.15 | $16.6K | 102,122 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2024-08-26 | 2024-08-28 | 149,655 | $0.33 | $49.4K | 1,203,204 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 1,053,549 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 981,217 | SEC↗ |
| BOTHA ROELOF | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 658,485 | SEC↗ |
| BOTHA ROELOF | Director | A Award | 2024-08-26 | 2024-08-28 | 179,586 | $0.33 | $59.3K | 483,526 | SEC↗ |
| Chung Patrick S | Director | A Award | 2024-08-26 | 2024-08-28 | 202,035 | $0.33 | $66.7K | 1,161,941 | SEC↗ |
| Chung Patrick S | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 959,906 | SEC↗ |
| Mohan Neal | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 904,291 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2024-08-26 | 2024-08-28 | 194,552 | $0.33 | $64.2K | 1,207,918 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 1,013,366 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2024-08-26 | 2024-08-28 | 658,485 | — | $0 | 895,961 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | F Tax w/h | 2024-08-20 | 2024-08-21 | 57,365 | $0.36 | $20.7K | 573,069 | SEC↗ |
| Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | F Tax w/h | 2024-08-20 | 2024-08-21 | 110,388 | $0.36 | $39.7K | 2,148,002 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2024-06-30 | 2024-07-02 | 57,515 | — | $0 | 395,064 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2024-06-30 | 2024-07-02 | 15,337 | — | $0 | 354,881 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2024-06-30 | 2024-07-02 | 57,515 | — | $0 | 322,732 | SEC↗ |
| Selsavage Joseph Anthony | Chief Financial & Actng Ofcr | A Award | 2024-05-21 | 2024-05-23 | 1,000,000 | — | $0 | 2,258,390 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | F Tax w/h | 2024-05-20 | 2024-05-21 | 16,106 | $0.55 | $8.9K | 630,434 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2024-05-20 | 2024-05-21 | 36,913 | $0.55 | $20.3K | 1,258,390 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2024-05-20 | 2024-05-21 | 35,282 | $0.55 | $19.4K | 1,217,033 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-05-02 | 2024-05-06 | 38,551 | — | $0 | 0 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-05-02 | 2024-05-06 | 38,551 | $0.49 | $18.9K | 1,252,315 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-05-02 | 2024-05-06 | 38,551 | $0.42 | $16.2K | 1,290,866 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-04-18 | 2024-04-19 | 38,548 | — | $0 | 38,551 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-04-18 | 2024-04-19 | 38,548 | $0.47 | $18.1K | 1,252,315 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-04-18 | 2024-04-19 | 38,548 | $0.42 | $16.2K | 1,290,863 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-04-04 | 2024-04-05 | 38,548 | — | $0 | 77,099 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-04-04 | 2024-04-05 | 38,548 | $0.42 | $16.2K | 1,290,863 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-04-04 | 2024-04-05 | 38,548 | $0.50 | $19.3K | 1,252,315 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-03-21 | 2024-03-22 | 38,548 | — | $0 | 115,647 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-03-21 | 2024-03-22 | 38,548 | $0.42 | $16.2K | 1,290,863 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-03-21 | 2024-03-22 | 38,548 | $0.46 | $17.7K | 1,252,315 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-03-07 | 2024-03-11 | 38,548 | — | $0 | 154,195 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-03-07 | 2024-03-11 | 38,548 | $0.53 | $20.4K | 1,252,315 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-03-07 | 2024-03-11 | 38,548 | $0.42 | $16.2K | 1,290,863 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-02-22 | 2024-02-23 | 38,548 | — | $0 | 192,743 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-02-22 | 2024-02-23 | 38,548 | $0.42 | $16.2K | 1,278,375 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-02-22 | 2024-02-23 | 38,548 | $0.61 | $23.5K | 1,239,827 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2024-02-20 | 2024-02-21 | 40,522 | $0.72 | $29.2K | 1,239,827 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2024-02-20 | 2024-02-21 | 42,395 | $0.72 | $30.5K | 1,273,659 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | F Tax w/h | 2024-02-20 | 2024-02-21 | 18,497 | $0.72 | $13.3K | 646,540 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-02-15 | 2024-02-16 | 38,548 | — | $0 | 231,291 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-02-15 | 2024-02-16 | 38,548 | $0.78 | $30.1K | 1,280,349 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-02-15 | 2024-02-16 | 38,548 | $0.42 | $16.2K | 1,318,897 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-01-25 | 2024-01-26 | 38,548 | — | $0 | 269,839 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-01-25 | 2024-01-26 | 38,548 | $0.42 | $16.2K | 1,318,897 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-01-25 | 2024-01-26 | 38,548 | $0.73 | $28.1K | 1,280,349 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2024-01-11 | 2024-01-12 | 38,548 | — | $0 | 308,387 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2024-01-11 | 2024-01-12 | 38,548 | $0.72 | $27.8K | 1,280,349 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2024-01-11 | 2024-01-12 | 38,548 | $0.42 | $16.2K | 1,318,897 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-12-28 | 2023-12-29 | 38,548 | — | $0 | 346,935 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-12-28 | 2023-12-29 | 38,548 | $0.42 | $16.2K | 1,318,897 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-12-28 | 2023-12-29 | 38,548 | $0.93 | $35.8K | 1,280,349 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-12-14 | 2023-12-18 | 38,548 | — | $0 | 385,483 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-12-14 | 2023-12-18 | 38,548 | $0.97 | $37.4K | 1,280,349 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-12-14 | 2023-12-18 | 38,548 | $0.42 | $16.2K | 1,318,897 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-11-30 | 2023-12-01 | 38,548 | — | $0 | 424,031 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-11-30 | 2023-12-01 | 38,548 | $0.42 | $16.2K | 1,318,897 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-11-30 | 2023-12-01 | 38,548 | $0.88 | $33.9K | 1,280,349 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2023-11-20 | 2023-11-21 | 6,208 | $0.91 | $5.6K | 1,316,054 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | F Tax w/h | 2023-11-20 | 2023-11-21 | 5,695 | $0.91 | $5.2K | 665,037 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2023-11-20 | 2023-11-21 | 4,627 | $0.91 | $4.2K | 1,280,349 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-11-16 | 2023-11-17 | 38,548 | — | $0 | 462,579 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-11-16 | 2023-11-17 | 38,548 | $0.77 | $29.7K | 1,284,976 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-11-16 | 2023-11-17 | 38,548 | $0.42 | $16.2K | 1,323,524 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-11-02 | 2023-11-03 | 38,548 | — | $0 | 501,127 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-11-02 | 2023-11-03 | 38,548 | $0.87 | $33.5K | 1,284,976 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-11-02 | 2023-11-03 | 38,548 | $0.42 | $16.2K | 1,323,524 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-10-19 | 2023-10-20 | 38,548 | — | $0 | 598,475 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-10-19 | 2023-10-20 | 38,548 | $0.81 | $31.2K | 1,284,976 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-10-19 | 2023-10-20 | 38,548 | $0.42 | $16.2K | 1,323,524 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-10-05 | 2023-10-06 | 38,548 | — | $0 | 637,023 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-10-05 | 2023-10-06 | 38,548 | $0.84 | $32.4K | 1,284,976 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-10-05 | 2023-10-06 | 38,548 | $0.42 | $16.2K | 1,323,524 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-09-21 | 2023-09-25 | 38,548 | — | $0 | 675,571 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-09-21 | 2023-09-25 | 38,548 | $1.00 | $38.5K | 1,284,976 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-09-21 | 2023-09-25 | 38,548 | $0.42 | $16.2K | 1,323,524 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | A Award deriv | 2023-09-15 | 2023-09-19 | 496,204 | — | $0 | 496,204 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | A Award deriv | 2023-09-15 | 2023-09-19 | 166,394 | — | $0 | 166,394 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | A Award deriv | 2023-09-15 | 2023-09-19 | 496,204 | — | $0 | 496,204 | SEC↗ |
| Wojcicki Anne | Chief Executive Officer | A Award deriv | 2023-09-15 | 2023-09-19 | 9,527,115 | — | $0 | 9,527,115 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | A Award | 2023-09-15 | 2023-09-19 | 1,025,992 | — | $0 | 1,284,976 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | A Award | 2023-09-15 | 2023-09-19 | 115,641 | — | $0 | 670,732 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | A Award | 2023-09-15 | 2023-09-19 | 344,050 | — | $0 | 555,091 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | A Award | 2023-09-15 | 2023-09-19 | 1,025,992 | — | $0 | 1,322,262 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-09-07 | 2023-09-11 | 40,896 | — | $0 | 714,119 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-09-07 | 2023-09-11 | 40,894 | $0.42 | $17.2K | 299,880 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-09-07 | 2023-09-11 | 40,894 | $1.06 | $43.3K | 258,984 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2023-09-06 | 2023-09-08 | 137,566 | — | $0 | 265,217 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2023-09-06 | 2023-09-08 | 55,045 | $1.09 | $60.0K | 193,379 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2023-09-06 | 2023-09-08 | 138,334 | — | $0 | 138,334 | SEC↗ |
| Chung Patrick S | Director | A Award | 2023-09-06 | 2023-09-08 | 61,926 | $1.09 | $67.5K | 301,421 | SEC↗ |
| Chung Patrick S | Director | A Award | 2023-09-06 | 2023-09-08 | 126,461 | — | $0 | 239,495 | SEC↗ |
| Mohan Neal | Director | A Award | 2023-09-06 | 2023-09-08 | 154,997 | — | $0 | 245,806 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2023-09-06 | 2023-09-08 | 130,862 | — | $0 | 279,911 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2023-09-06 | 2023-09-08 | 59,633 | $1.09 | $65.0K | 339,544 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2023-09-06 | 2023-09-08 | 165,088 | — | $0 | 237,476 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2023-09-06 | 2023-09-08 | 45,871 | $1.09 | $50.0K | 337,549 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2023-09-06 | 2023-09-08 | 148,492 | — | $0 | 291,678 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | S Sale | 2023-09-05 | 2023-09-06 | 2,538 | $1.08 | $2.7K | 211,041 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-08-24 | 2023-08-25 | 40,894 | — | $0 | 755,015 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-08-24 | 2023-08-25 | 40,894 | $1.05 | $42.9K | 252,512 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-08-24 | 2023-08-25 | 40,894 | $0.42 | $17.2K | 293,406 | SEC↗ |
| Richards William G | Head of Therapeutics Discove | F Tax w/h | 2023-08-20 | 2023-08-22 | 8,185 | $1.14 | $9.3K | 211,041 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2023-08-20 | 2023-08-22 | 6,209 | $1.14 | $7.1K | 286,537 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2023-08-20 | 2023-08-22 | 4,628 | $1.14 | $5.3K | 252,512 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-08-15 | 2023-08-16 | 40,894 | — | $0 | 795,909 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-08-15 | 2023-08-16 | 40,894 | $0.42 | $17.2K | 298,034 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-08-15 | 2023-08-16 | 40,894 | $1.32 | $54.0K | 257,140 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-07-27 | 2023-07-31 | 40,894 | — | $0 | 836,803 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-07-27 | 2023-07-31 | 40,894 | $0.42 | $17.2K | 298,034 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-07-27 | 2023-07-31 | 40,894 | $1.89 | $77.3K | 257,140 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-07-13 | 2023-07-14 | 40,894 | — | $0 | 877,697 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-07-13 | 2023-07-14 | 40,894 | $1.82 | $74.4K | 257,140 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-07-13 | 2023-07-14 | 40,894 | $0.42 | $17.2K | 298,034 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise deriv | 2023-06-29 | 2023-06-30 | 40,894 | — | $0 | 918,591 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2023-06-29 | 2023-06-30 | 40,894 | $1.72 | $70.3K | 257,140 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | M Exercise | 2023-06-29 | 2023-06-30 | 40,894 | $0.42 | $17.2K | 298,034 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | A Award | 2023-06-05 | 2023-06-07 | 37,808 | — | $0 | 305,821 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2023-06-05 | 2023-06-07 | 13,075 | $2.08 | $27.2K | 292,746 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | F Tax w/h | 2023-06-05 | 2023-06-07 | 15,347 | $2.08 | $31.9K | 221,876 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | A Award | 2023-06-05 | 2023-06-07 | 44,381 | — | $0 | 237,223 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2023-06-05 | 2023-06-07 | 15,098 | $2.08 | $31.4K | 257,140 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | A Award | 2023-06-05 | 2023-06-07 | 43,659 | — | $0 | 272,238 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2023-05-20 | 2023-05-23 | 4,628 | $1.94 | $9.0K | 228,579 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | F Tax w/h | 2023-05-20 | 2023-05-23 | 4,628 | $1.94 | $9.0K | 192,842 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2023-05-20 | 2023-05-23 | 6,209 | $1.94 | $12.0K | 268,013 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2023-02-20 | 2023-02-22 | 5,457 | $2.87 | $15.7K | 230,372 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2023-02-20 | 2023-02-22 | 7,321 | $2.87 | $21.0K | 269,957 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | F Tax w/h | 2023-02-20 | 2023-02-22 | 5,457 | $2.87 | $15.7K | 191,705 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | S Sale | 2022-12-05 | 2022-12-06 | 26,259 | $3.25 | $85.3K | 235,829 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | F Tax w/h | 2022-11-20 | 2022-11-22 | 4,628 | $2.99 | $13.8K | 197,162 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2022-11-20 | 2022-11-22 | 4,628 | $2.99 | $13.8K | 262,088 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | F Tax w/h | 2022-11-20 | 2022-11-22 | 10,105 | $2.99 | $30.2K | 277,278 | SEC↗ |
| SCHELLER RICHARD H | Director | S Sale | 2022-11-11 | 2022-11-14 | 18,421 | $3.24 | $59.7K | 72,388 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2022-09-06 | 2022-09-08 | 3,577 | $3.08 | $11.0K | 149,049 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 145,472 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 139,935 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2022-09-06 | 2022-09-08 | 3,251 | $3.08 | $10.0K | 143,186 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 127,651 | SEC↗ |
| Chung Patrick S | Director | A Award | 2022-09-06 | 2022-09-08 | 3,414 | $3.08 | $10.5K | 113,034 | SEC↗ |
| Chung Patrick S | Director | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 109,620 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 107,310 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2022-09-06 | 2022-09-08 | 3,251 | $3.08 | $10.0K | 110,561 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 90,809 | SEC↗ |
| Mohan Neal | Director | A Award | 2022-09-06 | 2022-09-08 | 14,633 | — | $0 | 90,809 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | A Award deriv | 2022-09-01 | 2022-09-02 | 190,131 | — | $0 | 190,131 | SEC↗ |
| Selsavage Joseph Anthony | Interim CFO | A Award | 2022-09-01 | 2022-09-02 | 129,761 | — | $0 | 287,383 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 113,018 | SEC↗ |
| Mohan Neal | Director | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 76,176 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 76,176 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 76,176 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2022-08-25 | 2022-08-29 | 16,501 | $3.03 | $50.0K | 92,677 | SEC↗ |
| Chung Patrick S | Director | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 76,176 | SEC↗ |
| Chung Patrick S | Director | A Award | 2022-08-25 | 2022-08-29 | 18,811 | $3.03 | $57.0K | 94,987 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 113,018 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2022-08-25 | 2022-08-29 | 17,821 | $3.03 | $54.0K | 130,839 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2022-08-25 | 2022-08-29 | 13,201 | $3.03 | $40.0K | 125,302 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2022-08-25 | 2022-08-29 | 57,755 | — | $0 | 112,101 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | S Sale | 2022-08-24 | 2022-08-25 | 8,753 | $3.64 | $31.9K | 196,083 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2022-08-20 | 2022-08-22 | 4,628 | $3.33 | $15.4K | 263,636 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | F Tax w/h | 2022-08-20 | 2022-08-22 | 4,628 | $3.33 | $15.4K | 204,836 | SEC↗ |
| Schoch Steven J | Chief Financial Officer | F Tax w/h | 2022-08-20 | 2022-08-22 | 4,782 | $3.33 | $15.9K | 211,663 | SEC↗ |
| Lovell Evan | Director | J Other deriv | 2022-08-11 | 2022-08-11 | 35 | — | $0 | 15 | SEC↗ |
| Lovell Evan | Director | J Other | 2022-08-11 | 2022-08-11 | 1,217,077 | — | $0 | 1,228,544 | SEC↗ |
| HIBBS KATHY L | Chief Administrative Officer | F Tax w/h | 2022-06-01 | 2022-06-02 | 4,627 | $2.82 | $13.0K | 268,264 | SEC↗ |
| Hillan Kenneth J. | Chief Therapeutics Officer | F Tax w/h | 2022-06-01 | 2022-06-02 | 4,627 | $2.82 | $13.0K | 209,464 | SEC↗ |
| Schoch Steven J | Chief Financial Officer | F Tax w/h | 2022-06-01 | 2022-06-02 | 4,782 | $2.82 | $13.5K | 216,445 | SEC↗ |
| Wojcicki Anne | Chief Executive Officer | A Award deriv | 2022-03-29 | 2022-03-30 | 7,500,000 | — | $0 | 7,500,000 | SEC↗ |
| Lovell Evan | Director | P Buy | 2022-03-10 | 2022-03-11 | 11,467 | $4.41 | $50.6K | 11,467 | SEC↗ |
| Hillan Kenneth J. | Head of Therapeutics | A Award deriv | 2022-02-09 | 2022-02-11 | 471,413 | — | $0 | 471,413 | SEC↗ |
| HIBBS KATHY L | Chief Legal Officer | A Award deriv | 2022-02-09 | 2022-02-11 | 471,413 | — | $0 | 471,413 | SEC↗ |
| Lemon Steven | Vice President, Engineering | A Award deriv | 2022-02-09 | 2022-02-11 | 314,276 | — | $0 | 314,276 | SEC↗ |
| Kohler Frederick Mark | Vice President, People | A Award deriv | 2022-02-09 | 2022-02-11 | 157,138 | — | $0 | 157,138 | SEC↗ |
| Keim Tracy | VP, Consumer Marketing & Bra | A Award deriv | 2022-02-09 | 2022-02-11 | 274,991 | — | $0 | 274,991 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2022-02-09 | 2022-02-11 | 471,413 | — | $0 | 471,413 | SEC↗ |
| Schoch Steven J | Chief Financial Officer | A Award deriv | 2022-02-09 | 2022-02-11 | 487,127 | — | $0 | 487,127 | SEC↗ |
| Hillan Kenneth J. | Head of Therapeutics | A Award | 2022-02-09 | 2022-02-11 | 214,091 | — | $0 | 214,091 | SEC↗ |
| HIBBS KATHY L | Chief Legal Officer | A Award | 2022-02-09 | 2022-02-11 | 214,091 | — | $0 | 272,891 | SEC↗ |
| Lemon Steven | Vice President, Engineering | A Award | 2022-02-09 | 2022-02-11 | 142,727 | — | $0 | 270,374 | SEC↗ |
| Kohler Frederick Mark | Vice President, People | A Award | 2022-02-09 | 2022-02-11 | 71,364 | — | $0 | 71,364 | SEC↗ |
| Keim Tracy | VP, Consumer Marketing & Bra | A Award | 2022-02-09 | 2022-02-11 | 124,886 | — | $0 | 124,886 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award | 2022-02-09 | 2022-02-11 | 214,091 | — | $0 | 1,312,308 | SEC↗ |
| Schoch Steven J | Chief Financial Officer | A Award | 2022-02-09 | 2022-02-11 | 221,227 | — | $0 | 221,227 | SEC↗ |
| HIBBS KATHY L | Chief Legal Officer | M Exercise deriv | 2022-01-06 | 2022-01-07 | 58,800 | — | $0 | 900,685 | SEC↗ |
| HIBBS KATHY L | Chief Legal Officer | M Exercise | 2022-01-06 | 2022-01-07 | 58,800 | $0.42 | $24.7K | 58,800 | SEC↗ |
| Lemon Steven | Vice President, Engineering | M Exercise deriv | 2022-01-05 | 2022-01-07 | 127,647 | — | $0 | 0 | SEC↗ |
| Lemon Steven | Vice President, Engineering | M Exercise | 2022-01-05 | 2022-01-07 | 127,647 | $0.23 | $29.4K | 127,647 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2021-12-03 | 2021-12-07 | 18,115 | — | $0 | 54,346 | SEC↗ |
| Hernandez Sandra R MD | Director | A Award | 2021-12-03 | 2021-12-07 | 36,231 | — | $0 | 36,231 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2021-11-01 | 2021-11-03 | 161,699 | — | $0 | 161,699 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2021-11-01 | 2021-11-03 | 656,540 | — | $0 | 656,540 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2021-11-01 | 2021-11-03 | 293,448 | — | $0 | 293,448 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2021-11-01 | 2021-11-03 | 983,582 | — | $0 | 983,582 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2021-11-01 | 2021-11-03 | 264,506 | — | $0 | 264,506 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award deriv | 2021-11-01 | 2021-11-04 | 414,886 | — | $0 | 414,886 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award | 2021-11-01 | 2021-11-03 | 352,004 | — | $0 | 1,098,217 | SEC↗ |
| Johnson Paul D | VP, General Manager-Consumer | A Award | 2021-11-01 | 2021-11-03 | 746,213 | — | $0 | 746,213 | SEC↗ |
| BOTHA ROELOF | Director, 10% Owner | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 18,421 | SEC↗ |
| Chung Patrick S | Director | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 18,421 | SEC↗ |
| Lovell Evan | Director | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 18,421 | SEC↗ |
| Mohan Neal | Director | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 18,421 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2021-09-14 | 2021-09-16 | 36,842 | — | $0 | 36,842 | SEC↗ |
| MONTGOMERY RICE VALERIE MD | Director | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 55,263 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 18,421 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2021-09-14 | 2021-09-16 | 36,842 | — | $0 | 36,842 | SEC↗ |
| Taylor Peter J. | Director | A Award | 2021-09-14 | 2021-09-16 | 18,421 | — | $0 | 55,263 | SEC↗ |